Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLIT and NTRK like family member 4 (SLITRK4) is a transmembrane protein belonging to the SLITRK family, characterized by two N-terminal leucine-rich repeat (LRR) domains similar to those in axon guidance proteins SLIT, and C-terminal regions with resemblance to neurotrophin receptors[1][3][5]. SLITRK4 is implicated in the regulation of neuronal development, with functions including suppression of neurite outgrowth and roles in synaptogenesis and synapse differentiation[1]. Altered function of its homologs in mammals has been linked to neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorder and certain brain tumors[1]. No interacting drugs or direct therapeutic applications have yet been approved, and its molecular mechanisms and possible clinical targeting remain subjects of ongoing research[1][3].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLIT and NTRK like family member 4 (SLITRK4).